Results 171 to 180 of about 48,384 (279)

Influence of a nationwide colorectal cancer screening program on the incidence of synchronous colorectal peritoneal metastases

International Journal of Cancer, Volume 157, Issue 2, Page 232-238, 15 July 2025.
What's new? Colorectal cancer screening has been shown to decrease the incidence of the disease and allow detection at an earlier stage. Here, the authors also show that, since the introduction of the colorectal cancer screening program in the Netherlands in 2014, the incidence of synchronous peritoneal metastases in colorectal cancer patients has ...
Laskarina J. K. Galanos, Anouk Rijken, Marloes A. G. Elferink, Niels F. M. Kok, Felice N. van Erning, Ignace H. J. T. De Hingh   +5 more
wiley   +1 more source

Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus

International Journal of Cancer, Volume 157, Issue 2, Page 371-383, 15 July 2025.
What's new? While estrogens, obesity, and alcohol are recognized risk factors for breast cancer, a viral hypothesis has been suggested based on the murine model of Mouse Mammary Tumor Virus (MMTV)‐induced mammary tumors. This study analyzed sequences of the human homolog of MMTV across human breast carcinoma histotypes, detecting the virus in all types
Prospero Civita, Chiara Maria Mazzanti, Francesca Lessi, Caterina Marchiò, Cristian Scatena, Michele Menicagli, Matteo Ghilli, Manuela Roncella, Antonio Giuseppe Naccarato, Anna Sapino, Jacob Hochman, Mauro Pistello, Generoso Bevilacqua   +12 more
wiley   +1 more source

Mucinous (Colloid) Adenocarcinoma of the Lung

Archives of Pathology & Laboratory Medicine, 2005
Ryan T. Mott, Victor L. Roggli, Annabelle Mahar, Noel A. Brownlee   +3 more
openaire   +3 more sources

Successful Tepotinib Treatment in <i>MET</i> Exon 14 Skipping Mutation-Positive Lung Adenocarcinoma With Idiopathic Pulmonary Fibrosis Through Nintedanib Combination. [PDF]

Respirol Case Rep
Kato Y, Ogawa T, Sato K, Matsukida A, Kawana A, Nagaoka R, Esaki K, Kimizuka Y.   +7 more
europepmc   +1 more source

KRAS and GNAS mutations in cell‐free DNA and in circulating epithelial cells in patients with intraductal papillary mucinous neoplasms—an observational pilot study

Molecular Oncology, Volume 19, Issue 7, Page 2144-2153, July 2025.
This study demonstrates that KRAS and GNAS mutations are more prevalent in patients with resected intraductal papillary mucinous neoplasms (IPMN) compared to those under clinical surveillance. GNAS mutations significantly differ between the two patient cohorts, indicating that their absence may serve as a potential biomarker to support conservative ...
Christine Nitschke, Marie Tölle, Philipp Walter, Kira Meißner, Mara Goetz, Jolanthe Kropidlowski, Andreas W. Berger, Jakob R. Izbicki, Felix Nickel, Thilo Hackert, Klaus Pantel, Harriet Wikman, Faik G. Uzunoglu   +12 more
wiley   +1 more source

Intraductal papillary mucinous neoplasm with gastric penetration diagnosed using endoscopic imaging and aspiration cytology. [PDF]

Endoscopy
Soga K, Hayakawa F, Yamaguchi M, Fujimoto Y, Shirahashi R, Kobori I, Tamano M.   +6 more
europepmc   +1 more source

A quantitative tumor‐wide analysis of morphological heterogeneity of colorectal adenocarcinoma

The Journal of Pathology: Clinical Research, Volume 11, Issue 4, July 2025.
Abstract The intertumoral and intratumoral heterogeneity of colorectal adenocarcinoma (CRC) at the morphologic level is poorly understood. Previously, we identified morphological patterns associated with CRC molecular subtypes and their distinct molecular motifs. Here we aimed to evaluate the heterogeneity of these patterns across CRC.
Mihnea P Dragomir, Vlad Popovici, Simon Schallenberg, Martina Čarnogurská, David Horst, Rudolf Nenutil, Fred Bosman, Eva Budinská   +7 more
wiley   +1 more source

Mucinous Cystadenocarcinoma Arising From a Mature Cystic Teratoma. [PDF]

Cureus
Rose BD, Madhala D, Priyathersini N.
europepmc   +1 more source

“Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

Advanced Healthcare Materials, Volume 14, Issue 17, July 4, 2025.
Schematic illustration of the mechanism of targeted delivery of nanoparticles including 1) paracellular, 2) endolysosomal escape, 3) receptor mediated endocytosis, and 4) M cell mediated transport for non‐GI diseases by oral administration such as atherosclerosis, cancer, diabetes, and brain diseases. Abstract Oral drug delivery is a promising approach
Subarna Ray, Shehzahdi S. Moonshi, Hang Thu Ta   +2 more
wiley   +1 more source

Cystic masses of the pancreas : how useful is cyst fluid analysis in the diagnosis? [PDF]

, 2011
Cesmeli, Ercan, Claerhout, Barbara, De Vos, Martine, Ferdinande, Liesbeth, Laurent, Stéphanie, Peeters, Marc   +5 more
core   +1 more source